Article ID,Publication Year,Reference,US$/QALY *,Ratio Description,PubMed ID,Target Population,Intervention Description,Title,Comparator Description,Impact
2020-01-34582,2020,Sathish 2020 BMC Med,160,"peer-support lifestyle intervention VERSUS booklet on lifestyle change IN Healthy; Age- 19 to 40 years, 41 to 64 years; Gender- Both; Country- India; Other- high risk of developing type 2 diabetes in the Indian state of kerala, indian diabetes risk score of >= 60.",32883279,"Healthy; Age- 19 to 40 years, 41 to 64 years; Gender- Both; Country- India; Other- high risk of developing type 2 diabetes in the Indian state of kerala, indian diabetes risk score of >= 60.",peer-support lifestyle intervention,Cost-effectiveness of a lifestyle intervention in high-risk individuals for diabetes  in a low- and middle-income setting: Trial-based analysis of the Kerala Diabetes  Prevention Program.,booklet on lifestyle change,NE
2020-01-34582,2020,Sathish 2020 BMC Med,51,"peer-support lifestyle intervention VERSUS booklet on lifestyle change IN Healthy; Age- 19 to 40 years, 41 to 64 years; Gender- Both; Country- India; Other- high risk of developing type 2 diabetes in the Indian state of kerala, indian diabetes risk score of >= 60.",32883279,"Healthy; Age- 19 to 40 years, 41 to 64 years; Gender- Both; Country- India; Other- high risk of developing type 2 diabetes in the Indian state of kerala, indian diabetes risk score of >= 60.",peer-support lifestyle intervention,Cost-effectiveness of a lifestyle intervention in high-risk individuals for diabetes  in a low- and middle-income setting: Trial-based analysis of the Kerala Diabetes  Prevention Program.,booklet on lifestyle change,NE
2020-01-34582,2020,Sathish 2020 BMC Med,52,"peer-support lifestyle intervention VERSUS booklet on lifestyle change IN Healthy; Age- 19 to 40 years, 41 to 64 years; Gender- Both; Country- India; Other- high risk of developing type 2 diabetes in the Indian state of kerala, indian diabetes risk score of >= 60.",32883279,"Healthy; Age- 19 to 40 years, 41 to 64 years; Gender- Both; Country- India; Other- high risk of developing type 2 diabetes in the Indian state of kerala, indian diabetes risk score of >= 60.",peer-support lifestyle intervention,Cost-effectiveness of a lifestyle intervention in high-risk individuals for diabetes  in a low- and middle-income setting: Trial-based analysis of the Kerala Diabetes  Prevention Program.,booklet on lifestyle change,NE
2014-01-16146,2014,Lutgens 2014 Gastrointest Endosc,Cost-Saving,Colonoscopic surveillance stragetry based on British Society of Gastroenterology VERSUS Colonoscopic surveillance stragetry based on American Gastroenterological Association (AGA) IN Specific disease- Inflammatory bowel disease (IBD); Age- 19 to 40 years; Gender- Male; Country- United States.,25088918,Specific disease- Inflammatory bowel disease (IBD); Age- 19 to 40 years; Gender- Male; Country- United States.,Colonoscopic surveillance stragetry based on British Society of Gastroenterology,A risk-profiling approach for surveillance of inflammatory bowel disease-colorectal carcinoma is more cost-effective: a comparative cost-effectiveness analysis between international guidelines.,Colonoscopic surveillance stragetry based on American Gastroenterological Association (AGA),SE
2014-01-15940,2014,Cocker 2014 PLoS One,Dominated,"Absenteeism (not working when feeling ill) over a five-year time horizon VERSUS Presenteeism (working while feeling ill) amongst employed Australians reporting lifetime major depressionover a five-year time horizon IN Specific disease- Major depression; Age- 0 to 18 years, 19 to 40 years, 41 to 64 years, >=65 years; Gender- Both; Country- Australia.",25181469,"Specific disease- Major depression; Age- 0 to 18 years, 19 to 40 years, 41 to 64 years, >=65 years; Gender- Both; Country- Australia.",Absenteeism (not working when feeling ill) over a five-year time horizon,Depression in working adults: comparing the costs and health outcomes of working  when ill.,Presenteeism (working while feeling ill) amongst employed Australians reporting lifetime major depressionover a five-year time horizon,NW
2014-01-15936,2014,Mewes 2014 J Cancer Surviv,33000,"Cognitive behavioral therapy for alleviating treatment-induced menopausal symptoms in breast cancer patients VERSUS Standard/Usual Care- Waiting list control group IN Healthy; Age- 0 to 18 years, 19 to 40 years, 41 to 64 years; Gender- Female; Country- Netherlands.",25179578,"Healthy; Age- 0 to 18 years, 19 to 40 years, 41 to 64 years; Gender- Female; Country- Netherlands.",Cognitive behavioral therapy for alleviating treatment-induced menopausal symptoms in breast cancer patients,Cost-effectiveness of cognitive behavioral therapy and physical exercise for alleviating treatment-induced menopausal symptoms in breast cancer patients.,Standard/Usual Care- Waiting list control group,NE
2014-01-15936,2014,Mewes 2014 J Cancer Surviv,41000,"Physical exercise to alleviate treatment-induced menopausal symptoms in breast cancer patients VERSUS Standard/Usual Care- Waiting list control group IN Healthy; Age- 0 to 18 years, 19 to 40 years, 41 to 64 years; Gender- Female; Country- Netherlands.",25179578,"Healthy; Age- 0 to 18 years, 19 to 40 years, 41 to 64 years; Gender- Female; Country- Netherlands.",Physical exercise to alleviate treatment-induced menopausal symptoms in breast cancer patients,Cost-effectiveness of cognitive behavioral therapy and physical exercise for alleviating treatment-induced menopausal symptoms in breast cancer patients.,Standard/Usual Care- Waiting list control group,NE
2014-01-15115,2014,Gordon 2014 Diabetes Res Clin Pract,Cost-Saving,"Telephone linked intervention VERSUS Standard/Usual Care- Not specified IN Specific disease- Type 2 Diabetes; Age- 0 to 18 years, 19 to 40 years, 41 to 64 years, >=65 years; Gender- Both; Country- Australia.",24503043,"Specific disease- Type 2 Diabetes; Age- 0 to 18 years, 19 to 40 years, 41 to 64 years, >=65 years; Gender- Both; Country- Australia.",Telephone linked intervention,A cost-effectiveness analysis of a telephone-linked care intervention for individuals with Type 2 diabetes.,Standard/Usual Care- Not specified,SE
2014-01-14208,2014,van der Have 2014 Dig Dis Sci,140000,"Hepatitis B Virus Screening (HbSAg, HbCAb), prior to TNF-a therapy. VERSUS No Hepatitis B Virus Screening IN Specific disease- Crohn's Disease; Age- 19 to 40 years, 41 to 64 years; Gender- Both; Country- Netherlands.",23949640,"Specific disease- Crohn's Disease; Age- 19 to 40 years, 41 to 64 years; Gender- Both; Country- Netherlands.","Hepatitis B Virus Screening (HbSAg, HbCAb), prior to TNF-a therapy.",Optimizing screening for tuberculosis and hepatitis B prior to starting tumor necrosis factor-alpha inhibitors in Crohn''s disease.,No Hepatitis B Virus Screening,NE
2014-01-14208,2014,van der Have 2014 Dig Dis Sci,93000,Extensive Tuberculosis Screening: initial screening with tuberculin skin test and chest X-ray followed by an IGRA (Quantiferon-TB Gold In-Tube) VERSUS conventional TB screening - including tuberculin skin test and chest X-ray IN Specific disease- Crohn's Disease; Age-; Gender- Both; Country- Netherlands.,23949640,Specific disease- Crohn's Disease; Age-; Gender- Both; Country- Netherlands.,Extensive Tuberculosis Screening: initial screening with tuberculin skin test and chest X-ray followed by an IGRA (Quantiferon-TB Gold In-Tube),Optimizing screening for tuberculosis and hepatitis B prior to starting tumor necrosis factor-alpha inhibitors in Crohn''s disease.,conventional TB screening - including tuberculin skin test and chest X-ray,NE
2013-01-11298,2013,Turkstra 2013 BMC Cardiovasc Disord,170000,Health coaching (HC) intervention: telephone-based health coaching to prevent coronary heart disease (CHD) VERSUS Standard/Usual Care IN Specific disease- myocardial infarction; Age- Adult; Gender- Both; Country- Australia.,23634982,Specific disease- myocardial infarction; Age- Adult; Gender- Both; Country- Australia.,Health coaching (HC) intervention: telephone-based health coaching to prevent coronary heart disease (CHD),Cost-effectiveness of a coronary heart disease secondary prevention program in patients with myocardial infarction: results from a randomised controlled trial (ProActive Heart).,Standard/Usual Care,NE
2012-01-09579,2012,Connolly 2012 Neth J Med,Cost-Saving,Mesalazine (2g) VERSUS Mesalazine (1g) IN Patients aged over 18 years with extensive ulcerative colitis in Netherlands,22859419,Patients aged over 18 years with extensive ulcerative colitis in Netherlands,Mesalazine (2g),The economics of mesalazine in active ulcerative colitis and maintenance in the Netherlands.,Mesalazine (1g),SE
2012-01-09579,2012,Connolly 2012 Neth J Med,Cost-Saving,Oral mesalazine (4g) + mesalazine enema (1g ) VERSUS Oral mesalazine (4g) + placebo enema IN Patients aged over 18 years with extensive ulcerative colitis in Netherlands,22859419,Patients aged over 18 years with extensive ulcerative colitis in Netherlands,Oral mesalazine (4g) + mesalazine enema (1g ),The economics of mesalazine in active ulcerative colitis and maintenance in the Netherlands.,Oral mesalazine (4g) + placebo enema,SE
1997-01-01928,1997,Salkeld 1997 Health Policy,1.4e+007,"Video + self help VERSUS Routine care IN Australian GP patients with >= 1 modifiable CVD risk factors, female",10169297,"Australian GP patients with >= 1 modifiable CVD risk factors, female",Video + self help,The cost-effectiveness of a cardiovascular risk reduction program in general practice,Routine care,NE
1997-01-01928,1997,Salkeld 1997 Health Policy,190000,"Video + self help VERSUS Routine care IN Australian GP patients with >= 1 modifiable CVD risk factors, male",10169297,"Australian GP patients with >= 1 modifiable CVD risk factors, male",Video + self help,The cost-effectiveness of a cardiovascular risk reduction program in general practice,Routine care,NE
1997-01-01928,1997,Salkeld 1997 Health Policy,38000,"Video VERSUS Routine care IN Australian GP patients with high risk of CVD (DBP>95 or TC>6.5), male",10169297,"Australian GP patients with high risk of CVD (DBP>95 or TC>6.5), male",Video,The cost-effectiveness of a cardiovascular risk reduction program in general practice,Routine care,NE
1997-01-01928,1997,Salkeld 1997 Health Policy,Dominated,"Video + self help VERSUS Video IN Australian GP patients with high risk of CVD (DBP>95 or TC>6.5), female",10169297,"Australian GP patients with high risk of CVD (DBP>95 or TC>6.5), female",Video + self help,The cost-effectiveness of a cardiovascular risk reduction program in general practice,Video,NW
1997-01-01928,1997,Salkeld 1997 Health Policy,Dominated,"Video + self help VERSUS Video IN Australian GP patients with high risk of CVD (DBP>95 or TC>6.5), male",10169297,"Australian GP patients with high risk of CVD (DBP>95 or TC>6.5), male",Video + self help,The cost-effectiveness of a cardiovascular risk reduction program in general practice,Video,NW
1997-01-01928,1997,Salkeld 1997 Health Policy,Dominated,"Video VERSUS Routine care IN Australian GP patients with >= 1 modifiable CVD risk factors, female",10169297,"Australian GP patients with >= 1 modifiable CVD risk factors, female",Video,The cost-effectiveness of a cardiovascular risk reduction program in general practice,Routine care,NW
1997-01-01928,1997,Salkeld 1997 Health Policy,Dominated,"Video VERSUS Routine care IN Australian GP patients with >= 1 modifiable CVD risk factors, male",10169297,"Australian GP patients with >= 1 modifiable CVD risk factors, male",Video,The cost-effectiveness of a cardiovascular risk reduction program in general practice,Routine care,NW
1Â 2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
